Concateno, the UK's largest drug and alcohol testing group, has received several bid approaches. The company has hired UBS to assess options including a possible sale of the business.A potential selling price has not yet been suggested to the company but it has been valued at £130 million.Concateno was established and supported by Marwyn Capital, an investment fund with a record of establishing cash shells.